STAAR Surgical Moves Second Quarter Earnings Release and Conference Call One Day to July 31
Moved to Thursday Allowing Senior Management Attendance at the Funeral Services for Hideo Watanabe, President of STAAR Japan
MONROVIA, Calif., July 28, 2014 /PRNewswire/ — STAAR Surgical Company (NASDAQ: STAA) a leading developer, manufacturer and marketer of implantable lenses and delivery systems for the eye has rescheduled the release of its second quarter results and conference call with investors to July 31, 2014 at 5:00 p.m. EDT from July 30, 2014. The Company rescheduled the release date and conference call to enable senior management attendance at the funeral services for Hideo Watanabe, President of STAAR Japan, who passed away of Sunday, July 27, 2014. Mr. Watanabe had been President of STAAR Japan since 2011.
“Hideo led our Japanese operations for the past three years and was a contributor to STAAR’s growing success in Japan and China. Hideo led the efforts on the manufacturing transfer of IOLs from Japan and also the efforts to increase sales results on IOLs in Japan. The entire STAAR team and Board of Directors mourn his passing and express our deepest condolences to his wife and three sons,” said Barry Caldwell, President & CEO of STAAR. “While we regret the inconvenience caused to our shareholders with the one day delay in our reporting results, I feel it was important for me to personally attend the funeral services for a friend of the Company, the ophthalmic industry and the employees of STAAR Surgical throughout the world.”
STAAR will host its conference call and webcast on Thursday, July 31 at 5:00 p.m. Eastern / 2:00 p.m. Pacific to discuss these results and recent corporate developments. The dial-in number for the conference call is 866-515-2907 for domestic participants and 617-399-5121 for international participants, both using the passcode 24164533. The Company will also be using slides to illustrate its second quarter results and operational progress. The slides and live webcast with accompanying slides can be accessed from the investor relations section of the STAAR website at www.staar.com.
A taped replay of the conference call will also be available beginning approximately one hour after the call’s conclusion for seven days. This replay can be accessed by dialing 888-286-8010 for domestic callers and 617-801-6888 for international callers, both using passcode 54025734. An archived video webcast will also be available at www.staar.com.
About STAAR Surgical
STAAR, which has been dedicated solely to ophthalmic surgery for over 25 years, designs, develops, manufactures and markets implantable lenses for the eye and delivery systems there for. All of these lenses are foldable, which permits the surgeon to insert them through a small incision. STAAR’s lens used in refractive surgery as an alternative to LASIK is called an Implantable Collamer® Lens or “ICL.” A lens used to replace the natural lens after cataract surgery is called an intraocular lens or “IOL.” More than 450,000 Visian ICLs have been implanted to date; to learn more about the ICL go to: www.visianinfo.com. STAAR has approximately 335 full time employees and markets lenses in over 60 countries. Headquartered in Monrovia, CA, it manufactures in Aliso Viejo, CA and Monrovia, CA. For more information, please visit the Company’s website at www.staar.com.
CONTACT: Investors Media EVC Group EVC Group Doug Sherk, 415-652-9100 Nicole Kruse, 212-850-6025
SOURCE STAAR Surgical